Predictors of Remission of Acromegaly following Surgical Treatment in Growth Hormone-Secreting Pituitary Adenoma
Journal of Neurological Surgery Part B: Skull Base · 01.06.2024 · 85 (03) · 261-266
DOI: 10.1055/s-0043-57233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.06.2024. Verfasst von Subhas Konar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background and Objective Surgery is the treatment of choice for growth hormone (GH)-secreting pituitary adenoma. The remission of random GH depends on various factors. We aimed to evaluate the predictors related to remission of random GH following surgical treatment.
Methods
We collected the data retrospectively from the chart review from a single unit of neurosurgery. The diagnostic criteria for remission were a random GH < 1 ng/mL or nadir GH < 0.4 ng/mL after an oral glucose tolerance test.
Results
Data from a total of 110 (females 62 [56.4%]) patients were available for follow-up and were analyzed. The mean age was 36.5 years (14–69 years). Vision impairments were seen in 39 (35.5%) patients. The mean duration of symptoms before surgery was 34 months. The mean volume of the tumor was 7.2 mL (0.44–109.8 mL). Knosp grade 3 and 4 tumors were seen in 41.5% of cases. The mean preoperative random GH level was 68.9 ng/mL. Transsphenoidal surgery was done in 107 (97.3%) cases. The gross total resection could be done in 36 (32.7%) cases. At 3 months, 25 (26%) patients had a biochemical remission. In univariable analysis, lower Knosp grade, preoperative GH level < 40 ng/mL, gross total resection, and male gender were associated with remission at 3 months. In regression analysis, preoperative GH and male gender were related to remission at 3 months.
Conclusion
The preoperative GH level < 40 ng/mL is associated with higher chances of remission after surgery for GH-secreting pituitary adenoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India.
- Department of Neurosurgery, Fortis Hospital Kalyan, Mumbai, Maharashtra, India.
- Department of Neurosurgery, RV Aster Hospital, Bangalore, Karnataka, India.
ORCID-Profile: Dhaval Shukla
Zitieren
APA
Konar, S., Yeole, U., Shukla, D., Bhat, D. I., Sadashiva, N., & Devi, B. I. (2024). Predictors of Remission of Acromegaly following Surgical Treatment in Growth Hormone-Secreting Pituitary Adenoma. Journal of Neurological Surgery Part B: Skull Base, 85(03), 261-266. https://doi.org/10.1055/s-0043-57233
Vancouver
Konar S, Yeole U, Shukla D, Bhat DI, Sadashiva N, Devi BI. Predictors of Remission of Acromegaly following Surgical Treatment in Growth Hormone-Secreting Pituitary Adenoma. Journal of Neurological Surgery Part B: Skull Base. 2024;85(03):261-266. doi:10.1055/s-0043-57233
BibTeX
@article{Konar2024,
author = {Konar, Subhas and Yeole, Ujwal and Shukla, Dhaval and Bhat, Dhananjaya I and Sadashiva, Nishanth and Devi, Bhagavatula Indira},
title = {Predictors of Remission of Acromegaly following Surgical Treatment in Growth Hormone-Secreting Pituitary Adenoma},
journal = {Journal of Neurological Surgery Part B: Skull Base},
year = {2024},
volume = {85},
number = {03},
pages = {261--266},
doi = {10.1055/s-0043-57233}
}
EUVIMED